Back to search

University of British Columbia

Process analytical utility of Raman spectroscopy for therapeutic T-cell manufacturing

Abstract

dc:description

New clinical therapies based on implanting living cells into patients have the potential to cure degenerative and deadly diseases. However, populations of living cells are far more inherently variable and complex than any molecular drug and cannot be purified or analyzed nearly as thoroughly. Stringent methods to validate critical process parameters during manufacturing and final cell product quality are essential to accelerate process development and to ensure long-term success of cell therapies. Immune cell therapies are an important category that have broad applications and are being investigated to treat a range of cancers and autoimmune diseases. Raman spectroscopy offers a label-free approach to distinguish cell types and physiological states by analyzing cellular macromolecular composition changes, having been used to identify cancers, evaluate stem cell differentiation, and detect modes of cell death. We developed a method to fix cells for Raman spectroscopy using physiological saline and air drying, which showed improved preservation of cellular macromolecular signals compared to traditional chemical fixatives. We validated our fixation method against Raman spectra collected from live cells and showed that observed spectral differences primarily arose from the hydration state of the sample, rather than macromolecular changes induced by the fixation. Then, using Raman microscopy with saline dry-fixed cells, we analyzed a 19-day regulatory T-cell manufacturing process, wherein we established consistent spectral profiles for cell expansion and identified deviations that indicate adverse culture outcomes, including cell death. We also analyzed blood-derived conventional T-cells, where we discovered spectral changes during activation and culture, and successfully distinguished CD4 and CD8 T-cell subtypes. These results reveal the strengths of Raman spectroscopy as a process analytical technology – a promising approach to provide a highly informative and potentially non-destructive means to enhance our ability to monitor, validate, and control the quality of cell therapy manufacturing. Importantly, given the variability of cell therapy manufacturing, this process analytical technology has the potential to provide feedback control of harvest timing and other manufacturing process operations, particularly with continuing advancements in Raman spectroscopy instrumentation and data analysis methods.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor dc:publisher
University of British Columbia
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rangan, Shreyas
Contributors dc:contributor
  • Piret, James
  • Turner, Robin F. B.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/95663

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Rangan, Shreyas. Process analytical utility of Raman spectroscopy for therapeutic T-cell manufacturing. doctoral thesis, University of British Columbia, 2026. http://hdl.handle.net/2429/95663